Companies: 10,795·Total market cap: $144.5T
Morphic Holding, Inc.

Morphic Holding, Inc.

MORFNASDAQHealthcare
$56.99
+$0.02(+0.04%)
Market Cap$2.9B
P/E Ratio—
52W High$57.0
52W Low$19.345
Free Cash FlowFinancialsRevenue

Morphic Holding, Inc. (MORF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MORF · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was −$113.6M for FY2023 (fiscal year ending 2023-12-31), down 12.0% year-over-year

FY2023 Free Cash Flow−$113.6M▼ -12.0% YoY
Trailing 12M (TTM)−$137.6Mtrailing 4 quarters sum
FCF Margin< −999%−$113.6M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
morf free cash flow history · morf free cash flow chart · morf free cash flow growth rate · morf free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2023Latest−$113.6M▼ 12.0%—
FY2022−$101.3M▼ 20.0%-143.1%
FY2021−$84.5M▼ 81.5%-426.8%
FY2020−$46.5M▼ 6.2%-103.5%
FY2019−$43.8M▼ 157.9%-258.1%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
morf free cash flow 2023 · morf free cash flow 2022 · morf free cash flow 2021 · morf operating cash flow

FCF valuation metrics

Morphic Holding, Inc. (MORF) reported negative free cash flow of −$0.11B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-12-31
morf price to free cash flow · morf free cash flow yield · morf free cash flow per share · morf price to cash flow ratio

Cash flow statement summary

For FY2023, Morphic Holding, Inc. generated −$112.3M in operating cash flow and spent 1M in capital expenditures, yielding −$113.6M in free cash flow.

Operating Activities
−$112.3M
Cash from core business operations
2023-12-31
Investing Activities
−$341.8M
CapEx, acquisitions & investments
2023-12-31
Financing Activities
+$453.4M
Buybacks, dividends & debt
2023-12-31
FCF FormulaOperating CF (−$112.3M) − |CapEx| (1M) = FCF (−$113.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →
morf cash flow statement · morf cash flow statement 2023 · morf operating cash flow · morf cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Morphic Holding, Inc.
Morphic Holding, Inc.YOU
MORF
−$113.6M-12.0%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Morphic Holding, Inc. (MORF) reported free cash flow of −$113.6M for FY2023 (fiscal year ending 2023-12-31), down 12.0% year-over-year.

Based on available data, Morphic Holding, Inc. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $75.7M in FY2018.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.
RevenueFinancial statementsNet incomeEarningsForecastPrice historyMarket capCash on handP/E ratio

Frequently asked questions

MORF free cash flow · 8 questions

Morphic Holding, Inc. free cash flow was −$113.6M for FY2023, down 12.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$137.6M.

MORF free cash flowMORF FCFMORF FCF 2023MORF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Morphic Holding, Inc. · Morphic Holding, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026